At the end of March 2016 NHS England published their business plan for 2016/17, which describes the organisation’s priorities for the forthcoming year. The document states that NHS England and its partners have made progress over the last year in bringing the vision of the NHS Five Year Forward View (5YFV) to life and it will continue...
The Department of Health has today issued further information on its consultation on the future of community pharmacy ahead of a stakeholder engagement event to be held on Thursday 28th April. Following the Department of Health’s 17th December 2015 letter to PSNC, they engaged in an initial phase of consultations with the wider group of stakeholders...
Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care landscape beyond community pharmacy. To help answer some of these questions and to help contractors and...
Early last year NHS England approached PSNC to seek support for a revised CPAF process. The new process included a short screening questionnaire consisting of 10 questions which all pharmacies would be asked to complete. The information yielded would be considered with other information collated by NHSBSA and a number of pharmacies would then be...
The Department of Health granted the following price concessions for April 2016: The price concession only applies to the month that it is granted. Drug Pack size Price concession Bumetanide 1mg tablets 28 £2.05 Celiprolol 400mg tablets 28 £39.65 Cimetidine 400mg tablets 60 £19.99 Desmopressin 10micrograms/dose nasal spray (new) 60 dose £24.00 Flecainide 50mg tablets 60 £7.50...
Recent Comments